🔎 Trials Near Me

Dachaigh › Schizophrenia › Texas

Sgrùdaidhean clionaigeach Schizophrenia ann an Texas

Tha 34 sgrùdaidhean airson Schizophrenia a’ lorg phàirtichean aig làraichean ann an Texas.

Bailtean ann an Texas

Teacsa sgrùdaidh oifigeil (Beurla)

Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

  • Haracec Clinical Research, El Paso
  • C-Trilogy Outreach, Longview
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07101094

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

  • Community Clinical Research, Inc., Austin
  • Pillar Clinical Research, LLC, Richardson
A’ fastadhÌre 1
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

  • Local Institution - 0049, Austin
  • Local Institution - 0194, Dallas
  • Pillar Clinical Research - Richardson, Richardson
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07686263

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

  • Neurocrine Clinical Site, Austin
  • Neurocrine Clinical Site, DeSoto
  • Neurocrine Clinical Site, Houston
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07114874

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

  • Texas Research Group, Coppell
  • PsyMed Solutions, Fort Worth
  • Kaleidoscope Clinical Research, Houston
  • agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 5 gu 17 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06229210

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

  • Neurocrine Clinical Site, DeSoto
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07227818

Study to Evaluate the Safety and Efficacy of Ublituximab in Participants With Schizophrenia

  • TG Therapeutics Investigational Trial Site, Richardson
A’ fastadhÌre 2
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07680946

A Study of Brenipatide in Adult Participants With Schizophrenia

  • Adams Clinical Dallas, DeSoto
  • Re:Cognition Health - Fort Worth, Fort Worth
A’ fastadhÌre 2
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07410507

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

  • Local Institution - 0149, Dallas
  • VAST Clinical Research, Garland
  • Local Institution - 0169, Houston
  • agus 2 a bharrachd
A’ fastadhÌre 3
Aoisean 5 gu 17 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07424404

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

  • Pillar Clinical Research, LLC, Richardson
A’ fastadhÌre 1
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT07734493

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

  • The University of Texas Health Science Center, Houston, Houston
A’ fastadh
Aoisean 22 gu 65 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT05276050

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

  • Community Clinical Research - Cross Park Drive /ID# 272977, Austin
  • Pillar Clinical Research - Richardson /ID# 275715, Richardson
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07145918

52-week Open Label Safety-Tolerability Study

  • Adams Clinical, DeSoto
  • Pillar Clinical Research, Richardson
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

  • VAST Clinical Research, Garland
  • Local Institution - 0120, Houston
  • Local Institution - 0066, Spring
A’ fastadhÌre 3
Aoisean 13 gu 17 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

  • Community Clinical Research, Austin
A’ fastadhÌre 1
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  • Clinical Site, Austin
  • Clinical Site, DeSoto
  • Clinical Site, Richardson
A’ fastadhÌre 2
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

  • Local Institution - 0016, Austin
  • Local Institution - 0050, Dallas
  • Local Institution - 0021, Fort Worth
  • agus 10 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT07379827

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

  • BioXcel Clinical Research Site, DeSoto
A’ fastadhÌre 1
Aoisean 10 gu 17 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05025605

Bilateral Prefrontal and Insular TMS for Depression in Schizophrenia

  • The University of Texas Health Science Center at Houston, Houston
A’ fastadh
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT07060066

Alternative Stimulation Mode and Location for Auditory Hallucination Neuromodulation Treatment

  • The University of Texas Health Science Center at Houston, Houston
A’ fastadh
Aoisean 18 gu 50 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT02916810

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)

  • The University of Texas Health Science Center, Houston, Houston
A’ fastadh
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT06345963

Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 2)

  • The University of Texas Health Science Center, Houston, Houston
A’ fastadh
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT06961916

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

  • Community Clinical Research, Austin
A’ fastadhÌre 2
Aoisean 18 gu 55 · Gach gnè · Air ùrachadh 23 Ògmh 2026 · NCT07191483

Deep Brain Stimulation for Psychosis

  • UT Southwestern Medical Center, Dallas
A’ fastadh
Aoisean 22 gu 70 · Gach gnè · Air ùrachadh 9 Ògmh 2026 · NCT06257056

A Study to Evaluate the Effect of KarXT on Urological Safety

  • Local Institution - 0001, Austin
  • InSite Clinical Research, DeSoto
A’ fastadhÌre 4
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT07221877

CLOZAPINE Response in Biotype-1

  • UT Southwestern Medical Center, Dallas
A’ fastadhÌre 4
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT04580134

Database Registry for Neural Network Biomarkers in Psychosis

  • University of Texas Southwestern Medical Center, Dallas
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 gu 60 · Gach gnè · Air ùrachadh 23 Gibl 2026 · NCT01409109

Ocrelizumab for Psychosis by Autoimmunity

  • Houston Methodist Research Institute, Houston
A’ fastadhÌre 1/2
Aoisean 18 gu 35 · Gach gnè · Air ùrachadh 1 Gibl 2026 · NCT03971487

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

  • University of Texas Southwestern Medical Center, Dallas
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 40 · Gach gnè · Air ùrachadh 10 Màrt 2026 · NCT06740383

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

  • Neurocrine Clinical Site, Austin
  • Neurocrine Clinical Site, DeSoto
  • Neurocrine Clinical Site, Houston
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 6 Màrt 2026 · NCT06963034

Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy

  • University of Texas at Dallas, Dallas
A’ fastadh
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 23 Faoi 2026 · NCT07098169

Randomized Withdrawal Study in Patients With Schizophrenia

  • Vanda Investigational Site, Austin
  • Vanda Investigational Site, Houston
  • Vanda Investigational Site, Irving
  • agus 1 a bharrachd
A’ fastadhÌre 3
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 12 Faoi 2026 · NCT06961968

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

  • Reviva site, Austin
  • Reviva site, Richardson
A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 19 Dùbh 2024 · NCT05184335

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.